Clinical trials

  • RITUXIMAB for Idiopathic steroid-sensitive nephrotic syndrome (SSNS) | Nephrotic syndrome
  • Iduronate-2-sulfatase fused to a Fc polypeptide that binds to the human transferrin receptor for Mucopolysaccharidosis Type II | Hunter syndrome
  • ABEMACICLIB for Hormone receptor-positive HER2-negative advanced/metastatic breast cancer
  • Carfilzomib for Smoldering multiple myeloma | Multiple myeloma
  • DEXAMETHASONE for Multiple myeloma
  • TUVUSERTIB for Epithelial ovarian cancer
  • DURVALUMAB for Urothelial carcinoma | Bladder cancer
  • AXITINIB for Metastatic renal cell carcinoma
  • OLAPARIB for Metastatic pancreatic cancer
  • CAPIVASERTIB for Hormone receptor positive HER2-negative advanced breast cancer
  • EPCORITAMAB for Diffuse large B-cell lymphoma | Relapsed or refractory diffuse large B-cell lymphoma
  • Methylprednisolone aceponate for Atopic dermatitis | Mild to moderate atopic dermatitis